Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Cytoskeleton-Dependent Mechanotransduction in Stress-Induced
2026-06-05
The reference study demonstrates that mechanical stress-induced autophagy in human cells is critically dependent on cytoskeletal integrity, especially microfilaments, with microtubules playing a supporting role. These findings advance the mechanistic understanding of how physical forces are transduced into autophagic signaling, informing experimental designs in cellular mechanobiology and calcium signaling research.
-
Reliable qRT-PCR: HyperScript™ RT SuperMix for qPCR in Lab A
2026-06-05
This article provides a scenario-driven evaluation of HyperScript™ RT SuperMix for qPCR (SKU K1074), focusing on its strengths in reproducibility, sensitivity, and workflow safety for gene expression analysis in cell viability and cytotoxicity assays. Drawing on real laboratory challenges and quantitative literature, we detail why this two-step reverse transcription kit—formulated with HyperScript Reverse Transcriptase—sets a practical standard for complex or low-abundance RNA workflows.
-
Oligomycin A (SKU A5588): Reliable Mitochondrial Inhibition
2026-06-04
This article addresses real-world laboratory challenges in cell viability and mitochondrial bioenergetics research, illustrating how Oligomycin A (SKU A5588) delivers reproducible, data-backed solutions. Drawing on protocol optimization, data interpretation, and vendor selection insights, we show how APExBIO’s Oligomycin A supports robust and sensitive workflows for advanced biomedical research.
-
MG-132 (Z-LLL-al): Optimizing Experimental Workflows in Apop
2026-06-04
Harness the full potential of MG-132 for apoptosis assays, cell cycle arrest studies, and oxidative stress research. Discover protocol enhancements, troubleshooting strategies, and key insights from recent breakthroughs that set APExBIO’s MG-132 apart in advanced experimental design.
-
ER-Targeted Peptide Self-Assembly: A Strategy for Selective
2026-06-03
The reference study introduces an endoplasmic reticulum (ER)-targeting peptide that undergoes enzyme-instructed self-assembly (EISA) in cancer cells, leveraging elevated alkaline phosphatase (ALP) activity for selective accumulation and induction of ER stress. This approach effectively enhances cancer cell death via apoptosis and necroptosis, demonstrating a significant improvement over previous EISA strategies by lowering concentration requirements and providing a platform for targeted cancer therapy.
-
10058-F4 C-Myc-Max Dimerization Inhibitor: Applied Protocols
2026-06-03
10058-F4, a targeted c-Myc-Max dimerization inhibitor, empowers advanced cancer and stem cell research by enabling precise control of oncogenic transcriptional programs and apoptosis pathways. This article unpacks protocol optimizations, real-world troubleshooting, and the latest mechanistic findings—providing a practical roadmap for reproducible bench success.
-
CH 223191: Potent AhR Antagonist for Dioxin Toxicity Researc
2026-06-02
CH 223191 is a highly selective aryl hydrocarbon receptor antagonist validated for inhibition of AhR signaling and dioxin toxicity mechanisms. It enables precise modulation of CYP1A1 expression and is indispensable for environmental toxicology and stem cell research applications.
-
Idoxuridine in Antiviral Research: From Mechanism to Strateg
2026-06-02
This thought-leadership article examines Idoxuridine’s mechanistic role as a viral DNA synthesis inhibitor, its significance for translational research workflows, and cross-domain lessons for antiviral discovery. Integrating recent advances in neuropathic pain research, we offer protocol guidance and a forward-looking perspective on Idoxuridine’s impact within a competitive scientific landscape.
-
G-1: Selective GPR30 Agonist for Pain, Cardiac, and Cancer M
2026-06-01
G-1 (CAS 881639-98-1), a selective GPR30 agonist from APExBIO, empowers research into non-classical estrogen signaling across pain, cardiac, and cancer models. Its high selectivity, potent activity, and robust performance in complex in vitro and in vivo protocols set a new standard for mechanistic and translational studies.
-
Resolving AhR Assay Challenges: Real-World Solutions with CH
2026-06-01
This article addresses common laboratory obstacles in AhR signaling pathway assays, focusing on reproducibility, specificity, and workflow optimization using CH 223191 (SKU A8609). Drawing from validated protocols and literature, we provide scenario-driven guidance for biomedical researchers and lab technicians seeking reliable data on AhR pathway inhibition, dioxin toxicity mechanisms, and cytochrome P450 1A1 modulation.
-
Methylation and Neurological Disorders: SAMe, Folate, and Me
2026-05-31
This review by Bottiglieri et al. elucidates the central role of methylation, particularly S-adenosylmethionine (SAMe), in neurological and psychiatric disorders. The study highlights how disruptions in methyl donor pathways, including those involving folate and vitamin B12, underlie conditions such as depression, dementia, and myelopathy, providing a foundation for targeted therapeutic research.
-
AICAR Phosphate (Acadesine): Mechanisms and Research Benchma
2026-05-30
AICAR phosphate (Acadesine) is a potent AMPK activator and apoptosis inducer with selective cytotoxicity for B-cell chronic lymphocytic leukemia (B-CLL) cells. Its mechanism involves caspase activation and mitochondrial cytochrome c release, as shown in peer-reviewed studies. This dossier details evidence, protocols, and boundaries for research use.
-
EdU Imaging Kits Empower High-Fidelity Cell Proliferation As
2026-05-29
The EdU Imaging Kits (HF488) revolutionize cell proliferation analysis with rapid, robust click chemistry-based DNA synthesis detection—outperforming BrdU assays in sensitivity and workflow efficiency. Explore how these kits accelerate research on drug response and resistance, as demonstrated in recent renal cell carcinoma studies.
-
E. coli Uracil-DNA Glycosylase (UDG): Technical Use & Protoc
2026-05-29
E. coli Uracil-DNA Glycosylase (UDG) is designed to excise uracil residues from DNA, addressing PCR product contamination and supporting DNA repair enzyme research. It is unsuitable for RNA work, oligonucleotides under six bases, or diagnostic applications.
-
AICAR Phosphate: Strategic AMPK Activation for Translational
2026-05-28
AICAR phosphate (Acadesine) is redefining the precision of apoptosis induction and immunometabolic modulation in translational cancer and CNS research. This article integrates mechanistic insights—anchored by recent discoveries in hypoxia-driven cognitive impairment and B-CLL apoptosis—with strategic guidance for leveraging APExBIO’s high-purity AICAR phosphate. We explore protocol considerations, competitive positioning, and translational frontiers to inform research leaders seeking to bridge cellular mechanism to clinical innovation.